Marschall S Runge - Net Worth and Insider Trading

Marschall S Runge Net Worth

The estimated net worth of Marschall S Runge is at least $11 Million dollars as of 2024-04-27. Marschall S Runge is the Director of Eli Lilly and Co and owns about 15,436 shares of Eli Lilly and Co (LLY) stock worth over $11 Million. Details can be seen in Marschall S Runge's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Marschall S Runge has not made any transactions after 2022-03-01 and currently still holds the listed stock(s).

Transaction Summary of Marschall S Runge

To

Marschall S Runge Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Marschall S Runge owns 1 companies in total, including Eli Lilly and Co (LLY) .

Click here to see the complete history of Marschall S Runge’s form 4 insider trades.

Insider Ownership Summary of Marschall S Runge

Ticker Comapny Transaction Date Type of Owner
LLY Eli Lilly and Co 2022-03-01 director

Marschall S Runge Latest Holdings Summary

Marschall S Runge currently owns a total of 1 stock. Marschall S Runge owns 15,436 shares of Eli Lilly and Co (LLY) as of March 1, 2022, with a value of $11 Million.

Latest Holdings of Marschall S Runge

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LLY Eli Lilly and Co 2022-03-01 15,436 733.51 11,322,460

Holding Weightings of Marschall S Runge


Marschall S Runge Form 4 Trading Tracker

According to the SEC Form 4 filings, Marschall S Runge has made a total of 1 transactions in Eli Lilly and Co (LLY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eli Lilly and Co is the acquisition of 202 shares on March 1, 2022, which cost Marschall S Runge around $49,850.

Insider Trading History of Marschall S Runge

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Marschall S Runge Trading Performance

GuruFocus tracks the stock performance after each of Marschall S Runge's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Marschall S Runge is 24.68%. GuruFocus also compares Marschall S Runge's trading performance to market benchmark return within the same time period. The performance of stocks bought by Marschall S Runge within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Marschall S Runge's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Marschall S Runge

Average Return

25.92%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 17.3 24.68 23.9 25.92 76.91
Relative Return to S&P 500(%) 11.74 29.44 31.78 34.16 67.7

Marschall S Runge Ownership Network

Ownership Network List of Marschall S Runge

No Data

Ownership Network Relation of Marschall S Runge


Marschall S Runge Owned Company Details

What does Eli Lilly and Co do?

Who are the key executives at Eli Lilly and Co?

Marschall S Runge is the director of Eli Lilly and Co. Other key executives at Eli Lilly and Co include Chief Accounting Officer Donald A Zakrowski , 10 percent owner Lilly Endowment Inc , and SVP & ERM & CECO Alonzo Weems .

Eli Lilly and Co (LLY) Insider Trades Summary

Over the past 18 months, Marschall S Runge made no insider transaction in Eli Lilly and Co (LLY). Other recent insider transactions involving Eli Lilly and Co (LLY) include a net sale of 3,779,086 shares made by Lilly Endowment Inc , a net sale of 3,220 shares made by Donald A Zakrowski , and a net sale of 2,148 shares made by Alonzo Weems .

In summary, during the past 3 months, insiders sold 398,671 shares of Eli Lilly and Co (LLY) in total and bought 0 shares, with a net sale of 398,671 shares. During the past 18 months, 3,795,454 shares of Eli Lilly and Co (LLY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,795,454 shares.

Eli Lilly and Co (LLY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eli Lilly and Co Insider Transactions

No Available Data

Marschall S Runge Mailing Address

Above is the net worth, insider trading, and ownership report for Marschall S Runge. You might contact Marschall S Runge via mailing address: Lilly Corporate Center, Indianapolis In 46285.

Discussions on Marschall S Runge

No discussions yet.